This profile has not been claimed and data may not be accurate.
89th percentile
Co-founder and CEO of Ginkgo Bioworks, YC-backed synthetic biology company taken public at $1.6B
Credibility
Traction · 85th percentile
- Ginkgo Bioworks went public via SPAC merger with Soaring Eagle Acquisition Corp. at a $1.6B valuation.
Relationship Matrix
Founder score
- 99%Probability of being accurate (99%)Current founder and CEO of Ginkgo Bioworks, a synthetic biology company he co-founded in 2008.
- 97%Probability of being accurate (97%)Ginkgo Bioworks is a Y Combinator Summer 2014 alum.
- 95%Probability of being accurate (95%)Ginkgo Bioworks went public via SPAC merger with Soaring Eagle Acquisition Corp. at a $1.6B valuation.
- 95%Probability of being accurate (95%)ginkgobioworks.com ranks #86,244 on the Majestic Million (global domain prominence).
- 90%Probability of being accurate (90%)Ginkgo Bioworks was co-founded by multiple co-founders alongside Jason Kelly.
- 85%Probability of being accurate (85%)Wikidata entity exists for Jason Kelly (Q114874203), confirming public notability.
- 50%Probability of being accurate (50%)Stack Overflow account has 2,665 reputation.
- 50%Probability of being accurate (50%)Identified Stack Overflow account for Jason Kelly with 2,665 reputation.
- 40%Probability of being accurate (40%)GitHub account identified for Jason Kelly, created in 2014 (account age ~11 years).
- 40%Probability of being accurate (40%)GitHub account for Jason Kelly has been active for approximately 11 years (created 2014).
- 35%Probability of being accurate (35%)OpenAlex identifies Jason F. Kelly as a researcher with an h-index of 10 and 979 citations.
What you likely need
You'd get the most out of Festival events that put you in rooms with AI-for-science builders, pharma and biotech R&D decision-makers, and fellow public-company CEOs navigating the same post-IPO growth pressures. Dinners and roundtables that let you pressure-test Ginkgo's platform narrative and Cloud Lab go-to-market will be especially high-signal. Peer CEO forums and thought leadership workshops round out the mix, giving you both the strategic fuel and the personal sustainability to lead through the next phase.
Would you attend these IRL Festival events?
We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.
- positioningA dinner for founders and researchers at the intersection of AI and wet-lab biology — think OpenAI for Science, Recursion, and Arc Institute leads — to pressure-test the autonomous lab architecture narrative ahead of Jason's planned technical white paper on Ginkgo's OpenAI collaboration
- introsA YC biotech and AI alumni roundtable pulling W05–W15 founders to surface warm partnership leads, early Cloud Lab customers, and potential co-founders for future ventures in Jason's pipeline
- hiringA closed dinner with VP- and SVP-level pharma and biotech R&D heads from companies like Pfizer, Merck, and Sanofi to walk through the $44/gene enzymatic function test and Cloud Lab as a cost-effective alternative to in-house lab infrastructure
- tacticalA roundtable with founders and BD leads who have closed federal science contracts — particularly DOE, DARPA, and NIH — to workshop how Jason can turn the POTUS-backed Genesis Mission partnership into a repeatable enterprise and government sales playbook
- wellbeingA peer forum dinner for CEOs of recently public deep-tech and biotech companies — think YPO-adjacent founders from Recursion, Absci, and Zymergen alumni — to share playbooks on sustaining leadership energy and board dynamics 17+ years into the founder-CEO journey
- positioningA happy hour with agtech and climate biotech founders and investors — including Breakthrough Energy Ventures and DCVC Bio LPs — to amplify Joyn Bio's milestone narrative and build Jason's public profile as a serial synthetic biology founder beyond the Ginkgo story
- positioningA small workshop dinner with founders who have built high-signal technical newsletters and Substacks in AI and science — think Lenny Rachitsky, Andrej Karpathy-adjacent writers, and Nature Biotechnology contributors — to help Jason architect his autonomous labs newsletter for maximum reach and credibility